1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. Consensus
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on BEIGENE, LTD.
Target Price consensus revisions : last 18 months
Recommendations (Chart) BEIGENE, LTD.
Analyst Recommendations on BEIGENE, LTD.
05/09Morgan Stanley Lowers BeiGene's Price Target to $300 From $338, Maintains Overweight Ratin..
MT
04/12Morgan Stanley Adjusts BeiGene's Price Target to $338 from $330, Keeps Overweight Rating
MT
03/17SVB Leerink Cuts BeiGene to Market Perform From Outperform, Price Target to $177 From $300
MT
03/01Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to $310.62 From $293.28
MT
03/01Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to HK$186.85 From HK$176..
MT
02/28Macquarie Lowers BeiGene's Price Target to $301.60 From $312.80, Maintains Outperform Rati..
MT
02/28Morgan Stanley Lowers BeiGene's Price Target to $330 From $360, Maintains Overweight Ratin..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 131,09 $
Average target price 309,79 $
Spread / Average Target 136%
High Price Target 470,00 $
Spread / Highest target 259%
Low Price Target 177,00 $
Spread / Lowest Target 35,0%
Consensus detail
Consensus revision (last 18 months)